CDC73 Mutational Status and Loss of Parafibromin in the Outcome of Parathyroid Cancer

Endocrine Connections - United Kingdom
doi 10.1530/ec-13-0046
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

Loss of Parafibromin Expression in a Subset of Parathyroid Adenomas

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2006English

SHP2 Converts Parafibromin/Cdc73 From Tumor Suppressor to Oncoprotein

Cancer Discovery
Oncology
2011English

Integrated Analysis of the Immunological and Genetic Status in and Across Cancer Types: Impact of Mutational Signatures Beyond Tumor Mutational Burden

OncoImmunology
OncologyAllergyImmunology
2018English

Expression Level of NRP1 and SMAD2 in Correlation to Mutational Status of Ras (BRAF) in Pancreatic Cancer

HPB
HepatologyGastroenterology
2019English

Different Metastatic Pattern According to the KRAS Mutational Status and Site-Specific Discordance of KRAS Status in Patients With Colorectal Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2012English

The Mutational Landscape of Phosphorylation Signaling in Cancer

Scientific Reports
Multidisciplinary
2013English

Mutational Status of FGFR3 in Oral Squamous Cell Carcinoma

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Nuclear MedicineRadiologyOral SurgeryImagingDentistryForensic MedicinePathologySurgery
2012English

Recurrent Loss of Heterozygosity Correlates With Clinical Outcome in Pancreatic Neuroendocrine Cancer

npj Genomic Medicine
GeneticsMolecular Biology
2018English

Influence of EGFR Mutational Status on Metastatic Behavior in Non Squamous Non Small Cell Lung Cancer

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy